Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neoandrographolide inhibits mature osteoclast differentiation to alleviate bone loss and treat osteoporosis

11 Feb 2025

Abstract excerpt

Background Osteoporosis (OP), as the prevalent systemic metabolic bone disease worldwide, progresses insidiously and slowly. The clinical discomfort and complications associated with OP impose a significant burden on patients. Therefore, finding more effective treatments for OP remains an urgent challenge. Method We first conducted in vitro experiments to determine whether Neoandrographolide (NEO) exhibits...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Metabolism and Diseases
Share to Clusterin in disease pathology

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 40008134
DOI: 10.3389/fphar.2025.1466057

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neoandrographolide inhibits mature osteoclast differentiation to alleviate bone loss and treat osteoporosisPMID 40008134Read ↗

Emerging Roles of Natural Compounds in Osteoporosis: Regulation, Molecular Mechanisms and Bone RegenerationSemantic proximity Read ↗

Sesamolin Protects Mice From Ovariectomized Bone Loss by Inhibiting Osteoclastogenesis and RANKL-Mediated NF-κB and MAPK Signaling PathwaysSemantic proximity Read ↗

Exploring the In Vitro Effects of Zingerone on Differentiation and Signalling Pathways in Bone Cell LinesSemantic proximity Read ↗

Peiminine Suppresses RANKL-Induced Osteoclastogenesis by Inhibiting the NFATc1, ERK, and NF-κB Signaling PathwaysSemantic proximity Read ↗

Minireview: Live and Let Die: Molecular Effects of Glucocorticoids on Bone CellsSemantic proximity Read ↗

Fat Extract Modulates Calcium Signaling and Protects Against Hyperactive Osteoclastogenesis in Bone Remodeling with Antioxidant CapacitySemantic proximity Read ↗

Cycloastragenol protects against glucocorticoid‐induced osteogenic differentiation inhibition by activating telomeraseSemantic proximity Read ↗

IKK/NF‐κB and ROS signal axes are involved in Tenacissoside H mediated inhibitory effects on LPS‐induced inflammatory osteolysisSemantic proximity Read ↗

Alpinetin Inhibits RANKL-Induced Osteoclastogenesis and Ovariectomy-Induced Bone Loss by Modulating NFATc1 Transcription and Lysosomal FunctionSemantic proximity Read ↗

Cortistatin prevents glucocorticoid-associated osteonecrosis of the femoral head via the GHSR1a/Akt pathwaySemantic proximity Read ↗

Novel approaches to the treatment of osteoporosisSemantic proximity Read ↗

Natural polyamines inhibit the migration of preosteoclasts by attenuating Ca2+-PYK2-Src-NFATc1 signaling pathways.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.